This page is part of the Genetic Reporting Implementation Guide (v2.0.0: STU 2) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Summary
Defining URL: | http://hl7.org/fhir/uv/genomics-reporting/ValueSet/genetic-therapeutic-implications-vs |
Version: | 2.0.0 |
Name: | GeneticTherapeuticImplicationsVS |
Title: | Genetic Therapeutic Implications |
Status: | Active as of 2022-05-09 04:53:07+0000 |
Definition: | Value Set for terms that describe a predicted ramification based on the presence of associated molecular finding(s). |
Publisher: | HL7 Clinical Genomics Working Group |
Copyright: | This material contains content from LOINC (http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc. This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement. |
Source Resource: | XML / JSON / Turtle |
References
This value set includes codes based on the following rules:
http://loinc.org
Code | Display |
LA10315-2 | Ultrarapid metabolizer |
LA25391-6 | Normal metabolizer |
LA25390-8 | Rapid metabolizer |
LA10317-8 | Intermediate metabolizer |
LA9657-3 | Poor metabolizer |
LA19542-2 | Low Risk |
LA19541-4 | High Risk |
LA6676-6 | Resistant |
LA6677-4 | Responsive |
LA9660-7 | Presumed resistant |
LA9661-5 | Presumed responsive |
LA6682-4 | Unknown Significance |
LA6675-8 | Benign |
LA6674-1 | Presumed Benign |
LA9662-3 | Presumed non-responsive |
LA25392-4 | Increased function |
LA25393-2 | Normal function |
LA25395-7 | Decreased function |
LA25394-0 | Poor function |
http://snomed.info/sct
Code | Display |
444734003 | Does not meet eligibility criteria for clinical trial (finding) |
399223003 | Patient eligible for clinical trial (finding) |
This value set contains 21 concepts
Expansion based on:
Code | System | Display |
LA10315-2 | http://loinc.org | Ultrarapid metabolizer |
LA25391-6 | http://loinc.org | Normal metabolizer |
LA25390-8 | http://loinc.org | Rapid metabolizer |
LA10317-8 | http://loinc.org | Intermediate metabolizer |
LA9657-3 | http://loinc.org | Poor metabolizer |
LA19542-2 | http://loinc.org | Low Risk |
LA19541-4 | http://loinc.org | High Risk |
LA6676-6 | http://loinc.org | Resistant |
LA6677-4 | http://loinc.org | Responsive |
LA9660-7 | http://loinc.org | Presumed resistant |
LA9661-5 | http://loinc.org | Presumed responsive |
LA6682-4 | http://loinc.org | Unknown Significance |
LA6675-8 | http://loinc.org | Benign |
LA6674-1 | http://loinc.org | Presumed Benign |
LA9662-3 | http://loinc.org | Presumed non-responsive |
LA25392-4 | http://loinc.org | Increased function |
LA25393-2 | http://loinc.org | Normal function |
LA25395-7 | http://loinc.org | Decreased function |
LA25394-0 | http://loinc.org | Poor function |
444734003 | http://snomed.info/sct | Does not meet eligibility criteria for clinical trial (finding) |
399223003 | http://snomed.info/sct | Patient eligible for clinical trial (finding) |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |